Se si verificano effetti indesiderati come disturbi gastrointestinali, consultare un medico
Key Products: Trevogrumab, anti-myostatin antibody designed to preserve lean muscle mass that was tested in combination with semaglutide to offset GLP-1-associated muscle loss
Regardless of coverage, researchers urge caution for patients seeking alternatives Despite growing evidence that GLP-1 medications improve health and are worth their cost, many insurance plans still limit coverage
So far, preclinical and observational data examining the effects of GLP1Ra-based therapies on bone suggest a positive association, whereby GLP1Ra use reduces turnover and promotes bone formation (Xie et al., 2025
Triglycerides fell by up to 41%, and low-density lipoprotein by roughly 20%
The study included 20 adults with a BMI of 30 or higher